Astrazeneca - PowerPoint PPT Presentation


COVID-19 Vaccines Regulatory Status Update - SAHPRA Review Details

Update on COVID-19 vaccine regulatory status as of January 25, 2021, provided by Dr. B. Semete-Makokotlela, SAHPRA CEO. The update includes information on vaccine applications submitted to SAHPRA, regulatory reviews conducted, and Section 21 applications for vaccines like Janssen, AstraZeneca, and C

1 views • 13 slides


Moderna Becomes Third Covid Vaccine Approved in the UK - Important Updates

The UK has approved Moderna as the third Covid vaccine, with logistical challenges due to required storage at -75C. AstraZeneca's vaccine is easier to distribute. Moderna offers nearly 95% protection from severe Covid, but all vaccines require a second dose for optimal immunity. Uncertainty remains

0 views • 7 slides



DAPA-HF Trial: Dapagliflozin in Heart Failure Patients without Diabetes

The DAPA-HF trial investigated the use of dapagliflozin, an SGLT2 inhibitor, in patients with heart failure and reduced ejection fraction, regardless of diabetes status. Funded by AstraZeneca, the study enrolled 4,744 patients from 20 countries, showing promising results in reducing cardiovascular d

3 views • 22 slides


Respiratory Health Insights and Updates by Dr. Zeina Aoun Bacha, MD

Explore key topics in respiratory health with Dr. Zeina Aoun Bacha, MD, including World Respiratory Diseases Day, Organizing Pneumonia, Sputnik Five Vaccine, and AstraZeneca Vaccine. Stay informed on important respiratory events and vaccination developments.

1 views • 10 slides


Buy AstraZeneca Online - dermafillerstore.com

Buy AstraZeneca Online is a global, science-led biopharmaceutical company that has been making strides in healthcare for decades. Established in 1999, the company has a rich history of producing high-quality, effective medications.\nText\/ WhatsApp:

1 views • 5 slides


Understanding the Oxford-AstraZeneca Vaccine: Benefits, Risks, and Recommendations

The Oxford-AstraZeneca vaccine has shown a likely but unproven link to cerebral venous sinus thrombus and other blood clotting issues. Despite this, the benefits of vaccination still outweigh the risks, with only approximately 4 cases per million resulting in death. Communication of the potential be

0 views • 10 slides